Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide
- 28 May 1997
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 52 (3) , 173-177
- https://doi.org/10.1007/s002280050270
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: